Gladstone Institutional Advisory LLC - XERIS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Gladstone Institutional Advisory LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$131
-33.5%
53,500
+10.3%
0.01%
-43.5%
Q2 2021$197
-10.0%
48,5000.0%0.02%
-32.4%
Q1 2021$219
-13.4%
48,500
-5.8%
0.03%
-32.0%
Q4 2020$253–51,500–0.05%–
 Download
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders